Pnets Prognostic Versus Predictive

Summary

Patients with pancreatic neuroendocrine tumors ( Perspectives from Lee Schwartzberg, MD Note: Dr Schwartzberg is a Medical Advisor for Biotheranostics, Inc. Website: onclive.com Twitter: twitter.com/OncLive Facebook: facebook.com/OncLive/ LinkedIn: ... E. David Crawford, MD, professor, Urologic and Radiation Oncology, head, Section of Urologic Oncology, University of Colorado ... Based on current trial data, global experts in the management of hepatocellular carcinoma (HCC) remark on the significance of ... There are many factors to consider when deciding on the appropriate treatment plan for patients with pancreatic neuroendocrine ... Dr. Kjell Oberg reviews the role of biomarkers in patient with During this opening segment of a one-on-one interview series, Peter Salgo, MD, discusses emerging diagnostic and Emerik Osterlund, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of circulating ... Jennifer Frontera, MD, New York University Grossman School of Medicine, New York, NY, discusses current efforts to elucidate ... Several therapeutic options exist in the treatment of pancreatic neuroendocrine tumors. Diane L. Reidy-Lagunes, MD, reviews the ... Minetta Liu, MD, Breast Cancer Specialist, Mayo Clinic, Rochester, Minnesota, discusses the use of circulating tumor cells (CTCs) ... Brenda Banwell, MD, FAAN, Children's Hospital of Philadelphia, Philadelphia, PA, discusses the importance of